Cardiovascular
Cardiovascular Function
0
Pipeline Programs↗
1
Active Trials↗
1
Companies Involved↗
Cardiovascular Function is an early-stage landscape with 0 programs across 1 company. The most active players are Boehringer Ingelheim.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
9
clinical trials
Completed6 · 67%
Unknown status1 · 11%
Terminated1 · 11%
Recruiting1 · 11%
Clinical Trials
Trial Activity
9 trials
Effects of Paroxetine on Cardiovascular Function in Septic Patients
Recruiting·UUniversidade do Extremo Sul Catarinense - Unidade Academica de Ciecias da Saude·Phase 2·NCT05725837·92 enrolled
Cannabis Inhalation: Effects on Cardiovascular Function During Rest and Exercise
Completed·—·Phase 1·NCT04693884·22 enrolled
Improvement of Cardiovascular Function After Bronchoscopic Lung Volume Reduction Using Endobronchial Valves
Unknown status·—·N/A·NCT04556942·40 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)